
Patient Success Story: Stem Cell Therapy in Japan
Patient Overview
The Quest for Vitality and Quality of Life
I am a 61-year-old man from Singapore.
As I have gotten older, I began noticing lower energy levels, fatigue, and slower physical recovery compared to before. I wanted to maintain my health, vitality, and quality of life so that I could continue enjoying both my work and personal life actively.
That was when I became interested in Stem Cell Therapy in Japan for anti-aging and overall wellness.
Although there are many lower-cost clinics available, I did not feel fully confident about their safety and quality standards. I was also concerned about treatments using donor-derived cells from other people.
For these reasons, I decided to pursue autologous stem cell therapy in Japan.
Personalized Care and Medical Reassurance
I also have high blood pressure and previously underwent stent placement treatment. Because of my medical history, I was initially worried about whether I would even be eligible for stem cell therapy.
After researching regenerative medicine clinics, I contacted CELL GRAND CLINIC in Osaka. What impressed me first was how quickly and professionally the clinic responded to my inquiry.
They carefully explained the stem cell treatment process in detail, and after reviewing my blood test results and imaging data, Dr. Yuichi Wakabayashi provided personalized counseling based on my physical condition.
On the day of my visit, the clinic also performed a carotid artery ultrasound examination and carefully checked the condition of my blood vessels. Dr. Wakabayashi clearly explained my vascular condition to me, which gave me a strong sense of reassurance.

He also explained that stem cells may help support vascular health and overall body condition management, which made me feel more confident about proceeding with treatment.
Strict Cell Quality Management Standards
One of the main reasons I chose treatment in Japan was the clinic’s strict cell quality management standards:
Honestly, I thought: “This is exactly the level of quality I would expect from Japan.”

I truly believe that investing in my health and body is worthwhile.
On the day of the fat tissue collection procedure, I also received an exosome IV infusion. To my surprise, I slept extremely well that night and felt deeply relaxed afterward.
The fat tissue collection itself was smooth and comfortable, and I felt the clinic carefully prioritized both safety and quality throughout the process.
Now, I am looking forward to receiving my high-quality cultured stem cells after approximately 7 weeks of preparation.
Why Choose Autologous Stem Cell Therapy?
Autologous therapy uses your own cells, eliminating the risk of rejection or ethical donor concerns.
Help support vascular health, energy levels, and overall body vitality as you age.
Benefit from strict purity and viability regulations that ensure high-potency cultured cells.
Experience personalized medical counseling and advanced vascular health checks.

Stem Cell Gallery at Cell Grand Clinic

Cell Grand Clinic has earned international recognition for its leadership in regenerative medicine and commitment to advancing patient-centered care. The clinic's founder, Dr. Yuichi Wakabayashi, was featured in the Business section of The Wall Street Journal, highlighting his pioneering work and innovative vision in the field of regenerative medicine.
Further demonstrating its dedication to clinical excellence, the clinic's leadership holds the prestigious American Board of Regenerative Medicine Certificate, reinforcing its reputation as an Advanced Stem Cell Clinic in Japan. Adding to these achievements, Cell Grand Clinic was recognized by Healthcare Business Review APAC as a Top Regenerative Medicine Solution in APAC for 2026, reflecting its growing influence and excellence in delivering cutting-edge regenerative healthcare solutions.
Recognized by Healthcare Business Review APAC as a Top Regenerative Medicine Solution in APAC (2026).
Peer-Reviewed Publication
Reflecting this commitment to transparency, Dr. Wakabayashi’s one-year outcome report on adipose-derived stem cell therapy for knee osteoarthritis was published in the peer-reviewed medical journal Cureus in 2026 (DOI: 10.7759/cureus.113830), adding independently verifiable clinical documentation to the clinic’s growing body of research.
Symptomatic Improvement Following Intra-articular Injection of Cultured Autologous Adipose-Derived Mesenchymal Stem Cells in Kellgren-Lawrence Grade 3 Knee Osteoarthritis: A Case Report With One-Year Follow-Up
Author: Yuichi Wakabayashi
Affiliation: Regenerative Medicine, Cell Grand Clinic, Osaka, Japan
Journal: Cureus
Year: 2026
Volume/Issue: 18(8)
Article: e113830
DOI: 10.7759/cureus.113830
Start Your Journey to Vitality Today
Are you looking to maintain your health and vitality like Patient S? Discover world-class options for Regenerative Medicine in Japan through PlacidWay and connect with verified clinics in Japan. Your health investment begins with a single step toward trusted expertise.
Consult with a Specialist Now

Share this listing